Abstract
Aluminum phosphide has been known, to be a major cause of non-accidental poisoning all over the world. The most common clinical manifestations being gastrointestinal and cardiovascular. Ocular manifestations have not been documented in the literature. We report a unique and rare presentation of aluminum phosphide poisoning. A 16 year old girl was brought with alleged ingestion of aluminum phosphide tablet and, developed redness and decreased vision in both the eyes. Visually Evoked Potential was suggestive of demyelinating optic neuropathy. She was treated with eye padding and eye drops to prevent dryness. Recovery and improvement in vision was seen after 5-6 days of ingestion. Aluminum phosphide poisoning may cause demyelinating optic neuropathy as a rare complication. In the presence of ocular symptoms, further ophthalmological and neurological evaluation is recommended. It is a diagnosis of exclusion and other possible etiologies must be ruled out before making the diagnosis.
| Original language | English |
|---|---|
| Pages (from-to) | 265-268 |
| Number of pages | 4 |
| Journal | Toxicology International |
| Volume | 23 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 01-09-2016 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Toxicology
- Health, Toxicology and Mutagenesis
Cite this
}
A case of acute aluminum phosphide poisoning leading to demyelinating optic neuropathy. / Kumar, Ashwini; Shashidhara, Sowmya; Bhaskarananda, Nalini; Kini, Sandesh.
In: Toxicology International, Vol. 23, No. 3, 01.09.2016, p. 265-268.Research output: Contribution to journal › Article
TY - JOUR
T1 - A case of acute aluminum phosphide poisoning leading to demyelinating optic neuropathy
AU - Kumar, Ashwini
AU - Shashidhara, Sowmya
AU - Bhaskarananda, Nalini
AU - Kini, Sandesh
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Aluminum phosphide has been known, to be a major cause of non-accidental poisoning all over the world. The most common clinical manifestations being gastrointestinal and cardiovascular. Ocular manifestations have not been documented in the literature. We report a unique and rare presentation of aluminum phosphide poisoning. A 16 year old girl was brought with alleged ingestion of aluminum phosphide tablet and, developed redness and decreased vision in both the eyes. Visually Evoked Potential was suggestive of demyelinating optic neuropathy. She was treated with eye padding and eye drops to prevent dryness. Recovery and improvement in vision was seen after 5-6 days of ingestion. Aluminum phosphide poisoning may cause demyelinating optic neuropathy as a rare complication. In the presence of ocular symptoms, further ophthalmological and neurological evaluation is recommended. It is a diagnosis of exclusion and other possible etiologies must be ruled out before making the diagnosis.
AB - Aluminum phosphide has been known, to be a major cause of non-accidental poisoning all over the world. The most common clinical manifestations being gastrointestinal and cardiovascular. Ocular manifestations have not been documented in the literature. We report a unique and rare presentation of aluminum phosphide poisoning. A 16 year old girl was brought with alleged ingestion of aluminum phosphide tablet and, developed redness and decreased vision in both the eyes. Visually Evoked Potential was suggestive of demyelinating optic neuropathy. She was treated with eye padding and eye drops to prevent dryness. Recovery and improvement in vision was seen after 5-6 days of ingestion. Aluminum phosphide poisoning may cause demyelinating optic neuropathy as a rare complication. In the presence of ocular symptoms, further ophthalmological and neurological evaluation is recommended. It is a diagnosis of exclusion and other possible etiologies must be ruled out before making the diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=85049587279&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049587279&partnerID=8YFLogxK
U2 - 10.22506/ti/2016/v23/i3/146723
DO - 10.22506/ti/2016/v23/i3/146723
M3 - Article
VL - 23
SP - 265
EP - 268
JO - Toxicology International
JF - Toxicology International
SN - 0971-6580
IS - 3
ER -